Patents by Inventor David R. Fischell

David R. Fischell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6179868
    Abstract: A balloon expandable metal stent is provided that includes a multiplicity of circumferential sets of strut members wherein at least two adjacent circumferential sets of strut members are coupled together by a plurality of undulating longitudinal struts. The stent is annealed to a degree where frictional forces existing in the longitudinal direction between adjacent circumferential sets of strut members and the balloon, during inflation, are greater than a force required to permanently deform the undulating longitudinal struts. Thus, the expansion of the space between adjacent circumferential sets of strut members during inflation of the balloon compensates for shortening of the stent that would otherwise occur during radial expansion of the stent responsive to the inflation of the balloon.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: January 30, 2001
    Inventors: Janet Burpee, David R. Fischell
  • Patent number: 6161045
    Abstract: Disclosed is a method for determining the optimal electrical stimulation parameters for intracranial stimulation therapy before implantation of a device for electrical stimulation therapy for epilepsy. This method would be used during intracranial electrical stimulation and monitoring procedures which are currently used to identify an epileptic region and map regional brain function prior to resective surgery. This method is used to determine therapeutic stimulation parameters during an evaluation procedure that can be carried out prior to the implantation of a closed-loop electrical stimulation device that is responsive to the onset of an epileptic seizure.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: December 12, 2000
    Assignee: NeuroPace, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Martha J. Morell, Barbara Gibb
  • Patent number: 6134474
    Abstract: Disclosed is a multiple electrode, closed-loop, responsive system for the treatment of certain neurological diseases such as epilepsy, migraine headaches and Parkinson's disease. Brain electrodes would be placed in close proximity to the brain or deep within brain tissue. When a neurological event such as the onset of an epileptic seizure occurs, EEG signals from the electrodes are processed by signal conditioning means in a control module that can be placed beneath the patient's scalp, within the patient's chest, or situated externally on the patient. Neurological event detection means in the control module will then cause a response to be generated for stopping the neurological event. The response could be an electrical signal to brain electrodes or to electrodes located remotely in the patient's body. The response could also be the release of medication or the application of a sensory input such as sound, light or mechanical vibration or electrical stimulation of the skin.
    Type: Grant
    Filed: January 15, 2000
    Date of Patent: October 17, 2000
    Assignee: NeuroPace, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Adrian R. M. Upton
  • Patent number: 6128538
    Abstract: Disclosed is a multiple electrode, closed-loop, responsive system for the treatment of certain neurological diseases such as epilepsy, migraine headaches and Parkinson's disease. Brain electrodes would be placed in close proximity to the brain or deep within brain tissue. When a neurological event such as the onset of an epileptic seizure occurs, EEG signals from the electrodes are processed by signal conditioning means in a control module that can be placed beneath the patient's scalp, within the patient's chest, or situated externally on the patient. Neurological event detection means in the control module will then cause a response to be generated for stopping the neurological event. The response could be an electrical signal to brain electrodes or to electrodes located remotely in the patient's body. The response could also be the release of medication or the application of a sensory input such as sound, light or mechanical vibration or electrical stimulation of the skin.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: October 3, 2000
    Assignee: NeuroPace, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Adrian R. M. Upton
  • Patent number: 6112116
    Abstract: Disclosed is a completely implantable system that can detect the occurrence of a myocardial infarction, i.e., a heart attack, and automatically inject a thrombolytic and/or anti-thrombogenic agent into the bloodstream to promptly dissolve the thrombus that caused the myocardial infarction and prevent the formation of additional thrombi. It is well known that a myocardial infarction can be detected from a patient's electrocardiogram by noting an ST segment voltage deviation as compared to the voltage of the patient's TP or PQ segments. Upon detection of a myocardial infarction, an ST segment deviation electronic detection circuit within the implanted device can produce an output signal that can cause a thrombolytic and/or anti-thrombogenic agent contained within an implanted, pressurized reservoir to immediately and automatically release medications into the patient's bloodstream.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: August 29, 2000
    Assignee: Cathco, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 6086604
    Abstract: The present invention provides for an expandable stent (10 or 20) for use in an artery or other vessel of a human body. The stent structure (10 or 20) maintains the patency of the vessel within which the stent (10 or 20) is expanded radially outward. One embodiment of the present invention is a stent (10) having a multiplicity of frames (12) joined together by at least two undulating longitudinal structures (14L and 14R) which can readily change their length in the longitudinal direction so as to provide increased longitudinal flexibility for the stent (10) for easy passage through and placement within a curved vessel such as a coronary artery. The stent (20) is an embodiment of the present invention having frames (22) joined with longitudinal structures (24B, 24T and 24R) and formed from a single, thin-walled piece of metal by laser cutting or chemical etching.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: July 11, 2000
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 6061593
    Abstract: Disclosed herein is a multiple electrode, closed-loop system for the treatment of certain neurological disorders such as epilepsy, migraine headaches and Parkinson's disease. Specifically, the present invention combines a multi-electrode array with sophisticated signal processing techniques to achieve reliable detection of the onset of a neurological event (such as an epileptic seizure or migraine headache) typically originating from a focus of limited spatial extent within the brain. It is highly desirable to detect an epileptic seizure at least 5 seconds before the onset of clinical symptoms. Since there is often a d-c shift in the EEG voltage more than 5 seconds before the seizure, disclosed herein is a means for utilizing the d-c shift of the EEG for early detection of the seizure.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: May 9, 2000
    Assignee: NeuroPace, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Adrian R. M. Upton
  • Patent number: 6017328
    Abstract: The present invention is an injection port assembly for subcutaneous delivery of medication. A single molded body has a soft cannula extending downward from a generally flat bottom surface and a self-sealing septum mounted at the center of a top surface which is generally of a concave shape sloping downward towards its outer perimeter at which point the single body is very thin. The single body also has a tubular extension which is directed outward parallel to the skin's surface. A metal needle which penetrates through the septum and through the lumen of the soft cannula is used for inserting the cannula through the skin. Once the soft cannula is placed subcutaneously, the needle is removed and an adhesive tape is placed over the single body and onto the skin beyond the body's outer perimeter.
    Type: Grant
    Filed: August 12, 1996
    Date of Patent: January 25, 2000
    Assignee: Magnolia Medical, LLC
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 6016449
    Abstract: Disclosed is a multiple electrode, closed-loop, responsive system for the treatment of certain neurological diseases such as epilepsy, migraine headaches and Parkinson's disease. Brain electrodes would be placed in close proximity to the brain or deep within brain tissue. When a neurological event such as the onset of an epileptic seizure occurs, EEG signals from the electrodes are processed by signal conditioning means in a control module that can be placed beneath the patient's scalp, within the patient's chest, or situated externally on the patient. Neurological event detection means in the control module will then cause a response to be generated for stopping the neurological event. The response could be an electrical signal to brain electrodes or to electrodes located remotely in the patient's body. The response could also be the release of medication or the application of a sensory input such as sound, light or mechanical vibration or electrical stimulation of the skin.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: January 18, 2000
    Assignee: NeuroPace, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Adrian R. M. Upton
  • Patent number: 6013019
    Abstract: The temporary radioisotope stent catheter system of the present invention includes a temporary radioisotope stent that is situated at a distal portion of two, co-axially situated, thin-walled tubes. The catheter system can be delivered into a vessel of a human body either as a stand-alone device or it can be used in conjunction with an elongated cylindrical sheath which is a form of delivery catheter. If used as a stand-alone device, the temporary radioisotope stent is first percutaneously advanced through a guiding catheter and is then placed at the site of a stenotic dilatation. An operating means located at a proximal portion of the catheter system is then used to increase the diameter of the temporary radioisotope stent to be approximately equal to the inside diameter of the dilated stenosis.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: January 11, 2000
    Assignee: IsoStent, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5976153
    Abstract: The present invention is a stent delivery catheter system for placing a stent within a stenosis in a vessel of a human body. The stent delivery catheter system utilizes a slideable sheath with a thin-walled distal portion that is situated coaxially over a stent that is placed onto a balloon located at the distal portion of a balloon angioplasty catheter. The distal end of a central portion of the sheath has an interior shoulder which is capable of exerting a distally directed push force on the balloon angioplasty catheter at a point that is just proximal to the stent. This push force is then transferred through the non-deployed stent to a gradually tapered, highly flexible, lubricity coated distal tip of the balloon angioplasty catheter.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: November 2, 1999
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5938689
    Abstract: Disclosed herein are several unique configurations of electrodes for stimulation of brain tissue. Specifically, a configuration of electrodes is disclosed that has at least one electrode on the brain's surface and at least one additional electrode located deep within the tissue of the brain. It is envisioned that all such electrodes would be located in close proximity to a particular region of the brain such as an epileptic focus. It is further envisioned that several brain surface electrodes would be used in conjunction with several deep brain electrodes. Specifically, it is envisioned that all surface electrodes would be electrically joined together and all deep electrodes would be electrically joined together.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: August 17, 1999
    Assignee: NeuroPace, Inc.
    Inventors: Robert E. Fischell, David R. Fischell
  • Patent number: 5913895
    Abstract: Disclosed herein is a thin-walled cylindrical stent in which one or more of the sets of strut members are more radially rigid after stent expansion as compared to other sets of strut members. Each set of strut members consists of a multiplicity of structural struts that are connected together with the struts extending circumferentially when the stent is outwardly radially deployed within a vessel of a human body. The sets of strut members are those parts of the stent which unfold during radial expansion and provide the radially rigid structure which maintains vessel patency. This invention is a stent structure specifically designed to have enhanced radial rigidity either at the ends or the center of the stent. More radially rigid end struts reduce injury to the vessel from over expansion at the ends of the stent. The embodiment of the present invention with enhanced rigidity in the center would be particularly useful for the treatment of calcified obstructions.
    Type: Grant
    Filed: June 2, 1997
    Date of Patent: June 22, 1999
    Assignee: IsoStent, Inc.
    Inventors: Janet W. Burpee, David R. Fischell
  • Patent number: 5910145
    Abstract: The present invention is a stent delivery catheter system for placing a stent within a stenosis in a vessel of a human body. The stent delivery catheter system utilizes a slideable sheath with a thin-walled distal portion that is situated coaxially over a stent that is placed onto a balloon located at the distal portion of a balloon angioplasty catheter. The distal end of a central portion of the sheath has an interior shoulder which is capable of exerting a distally directed push force on the balloon angioplasty catheter at a point that is just proximal to the stent. This push force is then transferred through the non-deployed stent to a gradually tapered, highly flexible, lubricity coated distal tip of the balloon angioplasty catheter.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: June 8, 1999
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5879282
    Abstract: A balloon catheter for irradiation with or without dilatation of an arterial stenosis has an inflatable balloon and a generally cylindrical, thin-walled, elastic radioactive source both located coaxially at a distal section of the balloon catheter. The elastic radioactive source is moved radially outward as a result of injection of an inflation fluid into the inflatable balloon thus placing the radioactive source in close proximity to the wall of a vessel of the human body into which the balloon catheter has been inserted.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: March 9, 1999
    Assignee: Cordis a Johnson and Johnson Company
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5879370
    Abstract: The present invention provides for an expandable stent (10 or 20) for use in an artery or other vessel of a human body. The stent structure (10 or 20) maintains the patency of the vessel within which the stent (10 or 20) is expanded radially outward. One embodiment of the present invention is a stent (10) having a multiplicity of frames (12) joined together by at least two undulating longitudinal structures (14L and 14R) which can readily change their length in the longitudinal direction so as to provide increased longitudinal flexibility for the stent (10) for easy passage through and placement within a curved vessel such as a coronary artery. The stent (20) is an embodiment of the present invention having frames (22) joined with longitudinal structures (24B, 24T and 24R) and formed from a single, thin-walled piece of metal by means of laser cutting or chemical etching.
    Type: Grant
    Filed: May 28, 1997
    Date of Patent: March 9, 1999
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5840009
    Abstract: Disclosed is a radioisotope stent that has increased radioactivity at the end regions of the stent as compared to the stent's central region. To minimize the neointimal hyperplasia that may exist to a greater extent at the ends of a stent that is implanted into an artery of a human body, the amount of radioactivity placed at or near the ends of the stent should be increased as compared to the amount of radioactivity over the remainder of the stent. It is an additional object of this invention to increase the radiation field at the end of a radioisotope stent by placing additional metal surfaces at the ends of the stent so as to have additional surfaces onto which a radioisotope can be placed.
    Type: Grant
    Filed: December 5, 1995
    Date of Patent: November 24, 1998
    Assignee: IsoStent, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5830227
    Abstract: The present invention is a balloon angioplasty catheter that combines a catheter shaft having increased pushability with an elongated, gradually tapered, highly flexible, lubricity coated, distal tip that is specifically designed to penetrate through a tight stenosis. The distal end of the tip is formed as a very thin-walled, tapered, frustrum of a cone that is capable of following a guide wire through even the most tortuous coronary arteries. The proximal end of the tip has a diameter that is equal to or slightly larger than the diameter of an angioplasty balloon that is wrapped around a catheter shaft at a distal section of the balloon angioplasty catheter. One embodiment of the invention includes a thin-walled tube located at the proximal end of the distal tip which extends over the distal end of the angioplasty balloon. This design can prevent the distal end of the wrapped pre-deployed balloon from engaging the arterial wall as it is pushed through a tight stenosis.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: November 3, 1998
    Assignee: IsoStent, Inc.
    Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell
  • Patent number: 5795286
    Abstract: This invention is a radioisotope impregnated material sheet or mesh designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This mesh or gauze into which the isotope is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL.TM. absorbable hemostat gauze-like sheet with a beta emitting radioisotope such as phosphorous-32 with has a relatively short effective range of approximately 4 mm, the biodegradable mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions.
    Type: Grant
    Filed: August 15, 1996
    Date of Patent: August 18, 1998
    Assignee: Cathco, Inc.
    Inventors: Robert E. Fischell, David R. Fischell
  • Patent number: 5792172
    Abstract: The present invention utilizes a balloon with three or more folds to more evenly distribute the frictional forces on the inside of a stent during stent deployment thus improving the uniformity of stent cell expansion. Ideally one would like to have the same number of balloon folds as the number of stent cells distributed circumferentially around the stent. Matching the number of balloon folds to the number of cells of each cylindrical segment of the stent provides better size uniformity for the stent cells after they are expanded against the wall or other vessel within a human body.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: August 11, 1998
    Assignee: IsoStent, Inc.
    Inventors: Robert E. Fischell, David R. Fischell